You are here: Welcome to the MPKB » Welcome to the MPKB » Marshall Protocol » Minocycline
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:mp:minocycline [07.04.2014] – paulalberthome:mp:minocycline [10.25.2018] – [Safety] sallieq
Line 2: Line 2:
 ====== Minocycline  ====== ====== Minocycline  ======
  
-<note important>The below article is an outdated summary of minocycline as it was used as part of the Marshall Protocol. The Marshall Protocol has since been changed to a monotherapy. Antibiotics, such as minocycline, are only used in select patients.</note> 
  
- +Minocycline hydrochloride, also known as minocycline, is a broad spectrum tetracycline antibiotic, and was the base antibiotic of the Marshall Protocol.
- +
-Minocycline hydrochloride, also known as minocycline, is a broad spectrum tetracycline antibiotic, and is the base antibiotic of the Marshall Protocol.+
  
 Minocycline is recognized as a DMARD (Disease-Modifying Anti-Rheumatic Drug) by the American College of Rheumatology, which recommends its use as a treatment for mild rheumatoid arthritis.(({{pubmed>long:18512708}})) To minimize its [[home:othertreatments:antibacterials:highdose|dose-dependent immunosuppressive effects]], the Marshall Protocol uses minocycline at doses [[home:protocol:mp_antibiotics:dosing|much lower]] than otherwise prescribed by rheumatologists. Minocycline is recognized as a DMARD (Disease-Modifying Anti-Rheumatic Drug) by the American College of Rheumatology, which recommends its use as a treatment for mild rheumatoid arthritis.(({{pubmed>long:18512708}})) To minimize its [[home:othertreatments:antibacterials:highdose|dose-dependent immunosuppressive effects]], the Marshall Protocol uses minocycline at doses [[home:protocol:mp_antibiotics:dosing|much lower]] than otherwise prescribed by rheumatologists.
  
 Either generic or brand name is appropriate to use. Either generic or brand name is appropriate to use.
 +
 +<note important>This article is an outdated summary of minocycline as it was used as part of the Marshall Protocol. The Marshall Protocol has since been changed to a monotherapy. Antibiotics, such as minocycline, are only used in select patients.</note>
 +
  
  
Line 63: Line 63:
  
 Minocycline has been in use for over 40 years yet continues to be effective against MRSA(({{pubmed>long:18221183}})) and to reduce disease severity even after follow-up several years later.(({{pubmed>long:10446869}})) Minocycline has been in use for over 40 years yet continues to be effective against MRSA(({{pubmed>long:18221183}})) and to reduce disease severity even after follow-up several years later.(({{pubmed>long:10446869}}))
-===== Combining minocycline with other Marshall Protocol antibiotics ===== 
  
- 
-<blockquote>We no longer see any reason to cut back on minocycline once you are at 100mg, except to manage uncontrollable immunopathology. When you are ready to manage an additional antibiotic, you should start at a very low dose of that additional antibiotic, to make sure the IP does not suddenly jump out of control. 
- 
-//**Trevor Marshall, PhD**//</blockquote> 
- 
- 
- 
-Minocycline may be combined with other MP antibiotics in the following fashion: 
- 
-  * **BCM** – Bactrim DS + clindamycin + minocycline  
-  * **CDM** – clindamycin + demeclocycline + minocycline  
-  *  
- 
-  
-Because demeclocycline and minocycline are similar, using the antibiotics in the same combination may offer a less severe immunopathological reaction than  other combinations. 
    
  
  
-{{tag>antibiotics}}+{{tag>Other_medication MP}}
  
 ===== Notes and comments ===== ===== Notes and comments =====
Line 112: Line 96:
  
   *Legacy content   *Legacy content
-   *+   * https://marshallprotocol.com/view_topic.php?id=55&forum_id=37
  
 ===== References ===== ===== References =====
home/mp/minocycline.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.